Abstract:Background: Permanent hypoparathyroidism is a significant complication after total thyroidectomy. This study aimed to evaluate the long-term impact of postoperative permanent hypoparathyroidism on kidney outcomes. Methods: Data of patients undergoing total thyroidectomy from 1999 to 2014 were retrieved. The estimated glomerular filtration rate was determined from serum creatinine results. Permanent hypoparathyroidism was defined as requiring oral calcium and vitamin D supplements postoperatively for at least 6 months. The primary outcome was a sustained decline in the estimated glomerular filtration rate from baseline by ≥50%. Secondary outcomes were end-stage kidney disease (a composite of sustained estimated glomerular filtration rate <15 mL/min/1.73 m2, need for dialysis, and kidney transplantation) and rate of estimated glomerular filtration rate decline. Patients with and without permanent hypoparathyroidism were compared. Multivariable Cox regression analysis was performed to identify independent risk factors for sustained estimated glomerular filtration rate decline by ≥50%. Results: In total, 3,245 patients were eligible for analysis; 418 patients (12.9%) had permanent hypoparathyroidism. Upon median follow-up of 11.6 years, more patients with permanent hypoparathyroidism had a sustained decline in estimated glomerular filtration rate from baseline by ≥50% compared to those without (15.6% vs 6.9%, P < .001). Similar findings were obtained on Kaplan-Meier analysis (P < .001). Permanent hypoparathyroidism was an independent risk factor for sustained estimated glomerular filtration rate decline by ≥50% (adjusted hazard ratio 2.77, P < .001). Other risk factors included age, preoperative estimated glomerular filtration rate <60 mL/min/1.73m2, and diabetes mellitus. Patients with permanent hypoparathyroidism had a more rapid estimated glomerular filtration rate decline (-1.60 vs -0.70 mL/min/1.73 m2/year, difference -0.91 mL/min/1.73m2/year, P < .001). Conclusion: Patients with postsurgical permanent hypoparathyroidism were at greater risk of renal impairment. Further research is warranted to improve the identification and preservation of parathyroid glands during thyroidectomy to minimize patient morbidity.

Causes of the Permanent Hypothyroidism in Patients with Hyperthyroidism and the Relations Between Hypothyroidism and the Treatment of 131I

Long-term effects on parathyroid function and risk factors for permanent hypoparathyroidism in post-surgical differentiated thyroid cancer patients treated with 131I: a retrospective analysis of clinical data

The Development and Current Status of 131I Treatment for Hyperthyroidism

Impact of Thyroid Cancer Treatment on Assisted Reproductive Technology Outcomes in Women with Infertility

Outcome of Radioiodine Therapy in Patients with Papillary Thyroid Carcinoma Concurrent with Hashimoto's Thyroiditis

Correlation Between TRAb and Early Onset Hypothyroidism After 131I Treatment for Graves' Disease

A Meta-Analysis of Risk Factors for Transient and Permanent Hypocalcemia After Total Thyroidectomy

[Hard Nut to Crack in Diagnosis of Pituitary Hyperplasia Secondary to Primary Hypothyroidism and Reasons of Misdiagnosis].

The effect of 131I on apoptosis of thyrocytes in patients with Graves disease

Long-term kidney outcomes in patients with permanent hypoparathyroidism after total thyroidectomy for benign disease: A population-based study

131I treatment of hyperthyroidism in children and adolescents

The Clinical Evaluation of Nontoxic Goiter after ~(131)I Therapy

Diagnosis and management of pituitary hyperplasia due to primary hypothyroidism

Hypothyroidism after radiation exposure: brief narrative review

Etiological Factors of Central Hypothyroidism

Analysis of 90 Cases of Antithyroid Drug-Induced Severe Hepatotoxicity over 13 Years in China

The Presence of Anti-TPO Antibodies Increase the Likelihood of Post-I131 Hypothyroidism

Risk factors of transient and permanent hypoparathyroidism after thyroidectomy: a systematic review and meta-analysis

Diagnostic options, physiopathology, risk factors and genetic causes of permanent congenital hypothyroidism: A narrative review

Effects of recombinant human thyroid stimulating hormone on 131I therapy for the treatment of differentiated thyroid cancer

High-dose radiation exposure and hypothyroidism: aetiology, prevention and replacement therapy